Law Firm | Canadian Lawyer

Vanda Pharmaceuticals Inc.

7 Dec 2023

Vanda acquires US, Canadian rights to Actelion's Ponvory oral therapy for $100 million

Deal TypeFinancing/Investment

IndustryHealthcare

Transaction Value$ 100,000,000

ClientsVanda Pharmaceuticals Inc., Actelion Pharmaceuticals Ltd.

Showing 1 to 1 of 1 entries

1

MOST ACTIVE FIRMS

01

Osler, Hoskin & Harcourt LLP

Case 232 | Deals 569

02

Stikeman Elliott LLP

Case 181 | Deals 564

03

Blake, Cassels & Graydon LLP

Case 228 | Deals 539

04

McCarthy Tétrault LLP

Case 395 | Deals 530

05

Torys LLP

Case 140 | Deals 408

RECENTLY ADDED CASES

May 20, 2026

Novartis Pharmaceuticals Canada Inc. et al. v. Apotex Inc.

May 20, 2026

Novartis Pharmaceuticals Canada Inc. et al. v. Apotex Inc.

May 20, 2026

Northern Reflections Ltd. v. Aritzia Inc et al

May 20, 2026

Viken Dekermejian v. AGC

May 20, 2026

Viken Dekermejian v. AGC